相似文献
1
Design, Synthesis, and Biological Evaluation of Structurally Rigid Analogues of 4-(3-Hydroxyphenyl)piperidine Opioid Receptor Antagonists.
J Org Chem. 2016 Nov 4;81(21):10383-10391. doi: 10.1021/acs.joc.6b01366. Epub 2016 Aug 2.
2
Investigation of the N-substituent conformation governing potency and mu receptor subtype-selectivity in (+)-(3R, 4R)-dimethyl-4-(3-hydroxyphenyl)piperidine opioid antagonists.
J Med Chem. 1998 May 21;41(11):1980-90. doi: 10.1021/jm980063g.
3
Identification of an opioid kappa receptor subtype-selective N-substituent for (+)-(3R,4R)-dimethyl-4-(3-hydroxyphenyl)piperidine.
J Med Chem. 1998 Dec 17;41(26):5188-97. doi: 10.1021/jm980511k.
4
Effect of the 3- and 4-methyl groups on the opioid receptor properties of N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines.
J Med Chem. 2014 Apr 10;57(7):3140-7. doi: 10.1021/jm500184j. Epub 2014 Mar 26.
5
Identification of the first trans-(3R,4R)- dimethyl-4-(3-hydroxyphenyl)piperidine derivative to possess highly potent and selective opioid kappa receptor antagonist activity.
J Med Chem. 2001 Aug 16;44(17):2687-90. doi: 10.1021/jm015521r.
6
N-Substituted 9beta-methyl-5-(3-hydroxyphenyl)morphans are opioid receptor pure antagonists.
J Med Chem. 1998 Oct 8;41(21):4143-9. doi: 10.1021/jm980290i.
7
Elucidation of the bioactive conformation of the N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine class of mu-opioid receptor antagonists.
J Med Chem. 2006 Dec 14;49(25):7278-89. doi: 10.1021/jm060486f.
8
N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists.
Bioorg Med Chem Lett. 1998 Nov 17;8(22):3149-52. doi: 10.1016/s0960-894x(98)00576-9.
9
N-substituted cis-4a-(3-hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists.
J Med Chem. 2005 Dec 29;48(26):8182-93. doi: 10.1021/jm058261c.
10
Synthesis and in vitro opioid receptor functional antagonism of methyl-substituted analogues of (3R)-7-hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide (JDTic).
J Med Chem. 2009 Dec 10;52(23):7463-72. doi: 10.1021/jm900756t.
引用本文的文献
1
Study of Cytotoxicity of 3-Azabicyclo[3.1.0]hexanes and Cyclopropa[]pyrrolizidines Spiro-Fused to Acenaphthylene-1(2)-one and Aceanthrylene-1(2)-one Fragments Against Tumor Cell Lines.
Int J Mol Sci. 2025 Apr 8;26(8):3474. doi: 10.3390/ijms26083474.
2
Study of Cytotoxicity of Spiro-Fused [3-Azabicyclo[3.1.0]hexane]oxindoles and Cyclopropa[a]pyrrolizidine-oxindoles Against Tumor Cell Lines.
Pharmaceuticals (Basel). 2024 Nov 25;17(12):1582. doi: 10.3390/ph17121582.
3
Biological Evaluation of 3-Azaspiro[Bicyclo[3.1.0]Hexane-2,5'-Pyrimidines] as Potential Antitumor Agents.
Int J Mol Sci. 2022 Sep 15;23(18):10759. doi: 10.3390/ijms231810759.
4
Access to 3D Alicyclic Amine-Containing Fragments through Transannular C-H Arylation.
Synlett. 2019 Mar;30(4):417-422. doi: 10.1055/s-0037-1610861. Epub 2019 Feb 5.
5
Synthesis of CHF-substituted 3-azabicyclo[3.1.0]hexanes by photochemical decomposition of CHF-pyrazolines.
RSC Adv. 2018 Jan 29;8(10):5114-5118. doi: 10.1039/c7ra13141k.
6
Efficient One-Pot, Two-Component Modular Synthesis of 3,5-Disubstituted Pyrazoles.
ACS Omega. 2018 Nov 15;3(11):15566-15574. doi: 10.1021/acsomega.8b02304. eCollection 2018 Nov 30.
本文引用的文献
1
A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic.
Neuropsychopharmacology. 2015 Aug;40(9):2059-65. doi: 10.1038/npp.2015.27. Epub 2015 Jan 23.
2
The discovery and development of the N-substituted trans-3,4-dimethyl-4-(3'-hydroxyphenyl)piperidine class of pure opioid receptor antagonists.
ChemMedChem. 2014 Aug;9(8):1638-54. doi: 10.1002/cmdc.201402142. Epub 2014 Jun 30.
3
Effect of the 3- and 4-methyl groups on the opioid receptor properties of N-substituted trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidines.
J Med Chem. 2014 Apr 10;57(7):3140-7. doi: 10.1021/jm500184j. Epub 2014 Mar 26.
4
Structure of the human κ-opioid receptor in complex with JDTic.
Nature. 2012 Mar 21;485(7398):327-32. doi: 10.1038/nature10939.
5
1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: a new series of potent and selective triple reuptake inhibitors.
J Med Chem. 2010 Mar 25;53(6):2534-51. doi: 10.1021/jm901818u.
6
N-substituted cis-4a-(3-hydroxyphenyl)-8a-methyloctahydroisoquinolines are opioid receptor pure antagonists.
J Med Chem. 2005 Dec 29;48(26):8182-93. doi: 10.1021/jm058261c.
7
Stereoselective cyclopropanation reactions.
Chem Rev. 2003 Apr;103(4):977-1050. doi: 10.1021/cr010007e.
8
Synthesis of trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonists: Application of the Cis-Thermal Elimination of Carbonates to Alkaloid Synthesis.
J Org Chem. 1996 Jan 26;61(2):587-597. doi: 10.1021/jo951403y.
9
Stereochemical influences upon the opioid ligand activities of 4-alkyl-4-arylpiperidine derivatives.
Chirality. 1989;1(3):202-8. doi: 10.1002/chir.530010305.
Zotero 插件